Acute hepatic porphyria (AHP) is a group of rare genetic disorders that affect the liver’s ability to produce heme, a vital component of blood, and can manifest with a variety of symptoms often ...

Acute Hepatic Porphyria (AHP) is a group of rare genetic liver disorders that can cause severe, life threatening attacks and long-term health issues that require monitoring. Treatment for AHP focuses ...

An acute hepatic porphyria (AHP) episode is a medical emergency with severe symptoms like intense pain and seizures. Having a pre-arranged emergency plan is crucial for prompt treatment and to avoid ...

Mattias Lissing from the Gastroenterology and Rheumatology Unit, at the Department of Medicine, Huddinge (MedH) is defending his thesis: "Liver transplantation, cancer risk and comorbidity in acute ...

Rare diseases can often be difficult to diagnose because their symptoms can overlap with a variety of conditions. One such disease is acute hepatic porphyria (AHP), a rare genetic disease with ...

Porphyric disorders encompass a spectrum of inherited abnormalities in the haem‐biosynthetic pathway, broadly classified into hepatic and erythropoietic subtypes. Acute hepatic porphyrias (AHP) ...

AIP is a rare genetic disorder affecting heme production, leading to a buildup of porphyrin precursors that can trigger acute episodes. AIP symptoms can range from abdominal pain and nausea to nerve ...

Crispr Therapeutics AG has expanded its in vivo pipeline with two new programs, which utilize lipid nanoparticle (LNP)-based delivery of CRISPR/Cas9 gene-editing cargo to the liver.